IQUR

iQur is at the forefront of vaccine research and development, using tandem core technology to create novel vaccines, currently being developed for influenza, malaria, human cytomegalovirus, dengue fever and hepatitis C. At iQur we are designing vaccines to provide protection against major global health challenges. We are targeting several different viruses using our patented proprietary technology and hope to bring benefit to people around the world by protecting them against a range of major pathogens.